Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis.

Source:http://linkedlifedata.com/resource/pubmed/id/11342601

J. Immunol. 2001 May 15 166 10 5878-81

Download in:

View as

General Info

PMID
11342601